These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35176754)

  • 1. Implications of obesity for drug administration and absorption from subcutaneous and intramuscular injections: A primer.
    Erstad BL; Barletta JF
    Am J Health Syst Pharm; 2022 Jul; 79(15):1236-1244. PubMed ID: 35176754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose-lowering effect of insulin by different routes in obese and lean nonketotic diabetic patients.
    Shahshahani MN; Kitabchi
    J Clin Endocrinol Metab; 1978 Jul; 47(1):34-40. PubMed ID: 400713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection.
    Jin JF; Zhu LL; Chen M; Xu HM; Wang HF; Feng XQ; Zhu XP; Zhou Q
    Patient Prefer Adherence; 2015; 9():923-42. PubMed ID: 26170642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aluminium toxicokinetics after intramuscular, subcutaneous, and intravenous injection of Al citrate solution in rats.
    Weisser K; Göen T; Oduro JD; Wangorsch G; Hanschmann KO; Keller-Stanislawski B
    Arch Toxicol; 2019 Jan; 93(1):37-47. PubMed ID: 30302509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramuscular risk at insulin injection sites--measurement of the distance from skin to muscle and rationale for shorter-length needles for subcutaneous insulin therapy.
    Hirsch L; Byron K; Gibney M
    Diabetes Technol Ther; 2014 Dec; 16(12):867-73. PubMed ID: 25329935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of concomitant administration of a measles, mumps and rubella vaccine (M-M-RvaxPro) and a varicella vaccine (VARIVAX) by intramuscular or subcutaneous routes at separate injection sites: a randomised clinical trial.
    Gillet Y; Habermehl P; Thomas S; Eymin C; Fiquet A
    BMC Med; 2009 Apr; 7():16. PubMed ID: 19366435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption of NPH (isophane) insulin in resting diabetic patients: evidence for subcutaneous injection in the thigh as the preferred site.
    Henriksen JE; Vaag A; Hansen IR; Lauritzen M; Djurhuus MS; Beck-Nielsen H
    Diabet Med; 1991 Jun; 8(5):453-7. PubMed ID: 1830531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous administration of benzathine benzylpenicillin G has favourable pharmacokinetic characteristics for the prevention of rheumatic heart disease compared with intramuscular injection: a randomized, crossover, population pharmacokinetic study in healthy adult volunteers.
    Kado JH; Salman S; Henderson R; Hand R; Wyber R; Page-Sharp M; Batty K; Carapetis J; Manning L
    J Antimicrob Chemother; 2020 Oct; 75(10):2951-2959. PubMed ID: 32696033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous vs intramuscular botulinum toxin: split-face randomized study.
    Gordin EA; Luginbuhl AL; Ortlip T; Heffelfinger RN; Krein H
    JAMA Facial Plast Surg; 2014; 16(3):193-8. PubMed ID: 24699554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramuscular versus subcutaneous injection of unmodified insulin: consequences for blood glucose control in patients with type 1 diabetes mellitus.
    Vaag A; Pedersen KD; Lauritzen M; Hildebrandt P; Beck-Nielsen H
    Diabet Med; 1990 May; 7(4):335-42. PubMed ID: 2140087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: a randomised non-inferiority clinical trial.
    Diez-Domingo J; Weinke T; Garcia de Lomas J; Meyer CU; Bertrand I; Eymin C; Thomas S; Sadorge C
    Vaccine; 2015 Feb; 33(6):789-95. PubMed ID: 25555381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and analgesic effects of intravenous, intramuscular or subcutaneous buprenorphine in dogs undergoing ovariohysterectomy: a randomized, prospective, masked, clinical trial.
    Steagall PV; Ruel HLM; Yasuda T; Monteiro BP; Watanabe R; Evangelista MC; Beaudry F
    BMC Vet Res; 2020 May; 16(1):154. PubMed ID: 32448336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of subcutaneous and intramuscular administrated buprenorphine in New Zealand White rabbits.
    Askar R; Fredriksson E; Manell E; Hedeland M; Bondesson U; Bate S; Olsén L; Hedenqvist P
    BMC Vet Res; 2020 Nov; 16(1):436. PubMed ID: 33176781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Bioavailability of Hydroxyprogesterone Caproate Administered via Intramuscular Injection or Subcutaneous Autoinjector in Healthy Postmenopausal Women: A Randomized, Parallel Group, Open-label Study.
    Krop J; Kramer WG
    Clin Ther; 2017 Dec; 39(12):2345-2354. PubMed ID: 29191450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuation of subcutaneous or intramuscular injectable contraception when administered by facility-based and community health workers: findings from a prospective cohort study in Burkina Faso and Uganda.
    MacLachlan E; Atuyambe LM; Millogo T; Guiella G; Yaro S; Kasasa S; Bukenya J; Nyabigambo A; Mubiru F; Tumusiime J; Onadja Y; Zan LM; Goeum/Sanon C; Kouanda S; Namagembe A
    Contraception; 2018 Nov; 98(5):423-429. PubMed ID: 30125558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of sulfamethoxypyridazine following intramuscular or subcutaneous administration in goats.
    Garg SK; Uppal RP
    Vet Res; 1997; 28(1):101-4. PubMed ID: 9172837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis.
    Westhovens R; Houssiau F; Joly J; Everitt DE; Zhu Y; Sisco D; Van Hartingsveldt B; Mascelli MA; Graham MA; Durez P; Bouman-Thio E
    J Rheumatol; 2006 May; 33(5):847-53. PubMed ID: 16583466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of low dose methotrexate bioavailability: oral solution, oral tablet, subcutaneous and intramuscular dosing.
    Jundt JW; Browne BA; Fiocco GP; Steele AD; Mock D
    J Rheumatol; 1993 Nov; 20(11):1845-9. PubMed ID: 8308768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of distance from skin surface to muscle for evaluation of the risk of inadvertent intramuscular insulin injection at potential injection sites among patients attending a tertiary care children's hospital in Sri Lanka-an observational study.
    Kodikara SKYI; Kalubowila J; Atapattu N; Warapitiya DS; Wijayabandara MDMS; Jayasekara LMDT; Arunthavanathan A; Kempitiya BCTANWMRCS; de Silva KSH; de Abrew K
    Arch Pediatr; 2020 Jul; 27(5):244-249. PubMed ID: 32461034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability and pharmacokinetic properties of ondansetron administered subcutaneously with recombinant human hyaluronidase in minipigs and healthy volunteers.
    Dychter SS; Harrigan R; Bahn JD; Printz MA; Sugarman BJ; DeNoia E; Haughey DB; Fellows D; Maneval DC
    Clin Ther; 2014 Feb; 36(2):211-24. PubMed ID: 24486335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.